- Home
- ZION vs BIO Comparison
ZION vs BIO Comparison
Compare ZION & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZION
- BIO
- Stock Information
- Founded
- ZION 1873
- BIO 1952
- Country
- ZION United States
- BIO United States
- Employees
- ZION N/A
- BIO N/A
- Industry
- ZION Major Banks
- BIO Biotechnology: Laboratory Analytical Instruments
- Sector
- ZION Finance
- BIO Industrials
- Exchange
- ZION Nasdaq
- BIO Nasdaq
- Market Cap
- ZION 8.6B
- BIO 9.6B
- IPO Year
- ZION N/A
- BIO N/A
- Fundamental
- Price
- ZION $59.03
- BIO $353.91
- Analyst Decision
- ZION Hold
- BIO Strong Buy
- Analyst Count
- ZION 19
- BIO 4
- Target Price
- ZION $57.06
- BIO $414.00
- AVG Volume (30 Days)
- ZION 1.4M
- BIO 154.6K
- Earning Date
- ZION 01-21-2025
- BIO 02-13-2025
- Dividend Yield
- ZION 2.92%
- BIO N/A
- EPS Growth
- ZION N/A
- BIO N/A
- EPS
- ZION 4.39
- BIO N/A
- Revenue
- ZION $3,010,000,000.00
- BIO $2,580,209,000.00
- Revenue This Year
- ZION N/A
- BIO N/A
- Revenue Next Year
- ZION $3.73
- BIO $2.92
- P/E Ratio
- ZION $13.46
- BIO N/A
- Revenue Growth
- ZION N/A
- BIO N/A
- 52 Week Low
- ZION $37.76
- BIO $262.12
- 52 Week High
- ZION $63.22
- BIO $387.99
- Technical
- Relative Strength Index (RSI)
- ZION 62.38
- BIO 61.58
- Support Level
- ZION $56.35
- BIO $334.57
- Resistance Level
- ZION $58.91
- BIO $355.05
- Average True Range (ATR)
- ZION 1.40
- BIO 10.56
- MACD
- ZION 0.56
- BIO 1.65
- Stochastic Oscillator
- ZION 98.89
- BIO 96.44
About ZION Zions Bancorporation N.A.
Zions Bancorporation is a regional us bank with core operations that span 11 states. The bank is headquartered in Salt Lake City and does business primarily in the Western and Southwestern United States. Zions primarily focuses on providing banking services to small and midsize businesses, with the bulk of its loans focused on commercial and commercial real estate lending.
About BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.